A Randomized Controlled Trial of a Novel Community-based Primary and Secondary Cardiovascular Prevention Program

VIP is a demonstration project with a goal to decrease modifiable risk factors for those with a higher risk of having a vascular event such as a heart attack or stroke or of developing vascular disease. Introduced as a study, VIP compares whether there is a significant reduction of modifiable vascular risk factors among patients who are involved in a personalized directed program versus those being provided standard care by their physician. Health care providers work collaboratively with the \'VIP Team\' to improve the participants\' vascular health.